{"id":91569,"date":"2024-01-09T22:54:39","date_gmt":"2024-01-09T22:54:39","guid":{"rendered":"https:\/\/www.atlasrleye.com\/?page_id=91569"},"modified":"2024-03-01T22:38:34","modified_gmt":"2024-03-01T22:38:34","slug":"caso-clinico-8","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/es\/oclusion-de-la-vena-central-de-la-retina\/caso-clinico-8\/","title":{"rendered":"Caso cl\u00ednico 8"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbENFERMEDADES VASCULARES DE LA RETINA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fatlas%2F%231636632711328-9e751f35-9f1e|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ add_icon=\u00bbtrue\u00bb css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading text=\u00bbOclusi\u00f3n de la Vena Central de la Retina – Caso Cl\u00ednico 8″ font_container=\u00bbtag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Foclusion-de-la-vena-central-de-la-retina%2F|title:OCLUSI%C3%93N%20DE%20LA%20VENA%20CENTRAL%20DE%20LA%20RETINA|\u00bb]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=\u00bb35″ equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_single_image image=\u00bb91583″ img_size=\u00bb280×250″ alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

OVCR hace dos meses, en una mujer sana de 19 a\u00f1os. La paciente relat\u00f3 que suspendi\u00f3 la p\u00edldora anticonceptiva e inici\u00f3 tratamiento con AAS.<\/span><\/p>\n

 <\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_single_image image=\u00bb91587″ img_size=\u00bb350×120″ alignment=\u00bbcenter\u00bb onclick=\u00bblink_image\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

OCT 9 a\u00f1os despu\u00e9s. AV: 20\/20 OD. Fue tratada con inyeccion intrav\u00edtrea de bevacizumab y inyeccion subtenon de triamcinolona.<\/span><\/p>\n

 <\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluaciones
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=\u00bb99″ no_fill=\u00bbtrue\u00bb collapsible_all=\u00bbtrue\u00bb][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb1\u00aa Evaluaci\u00f3n – 05 02 2014″ tab_id=\u00bb1643041606202-1195a575-0f51″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Angiograf\u00eda con fluoresce\u00edna<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91418,91422,91426,91430″ img_size=\u00bb193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91438″ img_size=\u00bb251×206″][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91454″ img_size=\u00bb185×206″][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91450″ img_size=\u00bb185×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91458,91406,91410,91414″ img_size=\u00bb307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Fotografia del Segmento Anterior<\/p>\n

\n

P\u00e9rdida s\u00fabita de la visi\u00f3n en el OD hace dos meses. AV OI: 20\/15.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91434″ img_size=\u00bb300×206″ css=\u00bb.vc_custom_1706224334445{margin-top: -30px !important;}\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2″][vc_column_text]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91446,91442″ img_size=\u00bb245×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb2\u00aa Evaluaci\u00f3n – 05 01 2015″ tab_id=\u00bb1704840897711-8212433c-f1d9″][vc_row_inner][vc_column_inner width=\u00bb2\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91498,91486″ img_size=\u00bb251×206″][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91494″ img_size=\u00bb193×206″][\/vc_column_inner][vc_column_inner width=\u00bb1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91490″ img_size=\u00bb193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text]<\/p>\n

\n
\n

Perimetry<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91474,91478″ img_size=\u00bb143×206″][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

RNFL \u2013 Mapa de espesor<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91470″ img_size=\u00bb143*206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

AV: 20\/30 OD. Fue tratada con inyeccion intrav\u00edtrea de bevacizumab y inyeccion subtenon de triamcinolona.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91462,91466″ img_size=\u00bb307×110″ css=\u00bb.vc_custom_1706224375259{margin-top: -30px !important;}\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91482″ img_size=\u00bb245×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=\u00bbfar fa-calendar-alt\u00bb add_icon=\u00bbtrue\u00bb title=\u00bb3\u00aa Evaluaci\u00f3n – 10 10 2023″ tab_id=\u00bb1704841221078-0e876701-2834″][vc_row_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescencia<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91526″ img_size=\u00bb251×206″][\/vc_column_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text]<\/p>\n

\n
\n

Fotografia del Segmento Anterior<\/p>\n

\n

AV: 20\/20 OD, 20\/20 OI. Catarata OD.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91518″ img_size=\u00bb300*206″ css=\u00bb.vc_custom_1706224523503{margin-top: -30px !important;}\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

RNFL \u2013 Mapa de espesor<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91514″ img_size=\u00bb300*206″][\/vc_column_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text]<\/p>\n

\n
\n

OCTA<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91530,91534″ img_size=\u00bb300×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb2\/3″][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91502,91506″ img_size=\u00bb307×110″][\/vc_column_inner][vc_column_inner width=\u00bb1\/3″][vc_column_text]<\/p>\n

\n
\n

Retinograf\u00eda color<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=\u00bbimage_grid\u00bb images=\u00bb91522″ img_size=\u00bb245×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=\u00bbENFERMEDADES VASCULARES DE LA RETINA\u00bb font_container=\u00bbtag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Fatlas%2F%231636632711328-9e751f35-9f1e|\u00bb][vc_text_separator title=\u00bb\u00bb i_icon_fontawesome=\u00bbfas fa-eye\u00bb i_color=\u00bbcustom\u00bb i_size=\u00bblg\u00bb color=\u00bbcustom\u00bb border_width=\u00bb8″ add_icon=\u00bbtrue\u00bb css=\u00bb.vc_custom_1637080776101{margin-bottom: -5px !important;}\u00bb accent_color=\u00bb#bababa\u00bb i_custom_color=\u00bb#bababa\u00bb][vc_custom_heading text=\u00bbOclusi\u00f3n de la Vena Central de la Retina – Caso Cl\u00ednico 8″ font_container=\u00bbtag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=\u00bbyes\u00bb link=\u00bburl:https%3A%2F%2Fwww.atlasrleye.com%2Fes%2Foclusion-de-la-vena-central-de-la-retina%2F|title:OCLUSI%C3%93N%20DE%20LA%20VENA%20CENTRAL%20DE%20LA%20RETINA|\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=\u00bb35″ equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2″][vc_row_inner][vc_column_inner […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":75922,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-91569","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/91569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/comments?post=91569"}],"version-history":[{"count":7,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/91569\/revisions"}],"predecessor-version":[{"id":94157,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/91569\/revisions\/94157"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/pages\/75922"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/es\/wp-json\/wp\/v2\/media?parent=91569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}